Oncology Informatics Market Share, Covid-19 Impact Analysis, Growth, Business Challenges

Global Oncology Informatics Market- By Type (Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support System (CDSS), Drug Discovery and Development Informatics), By Application (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Others), By End Use (Pharmaceutical Industry, Life Science Industry, Contract Research Organizations (CROs), Academic Institutes and Research Centers, Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2020-2027.

Published: Jun-2021	Report ID: HLCA2134	Pages: 1 - 250	Formats^*:
Category : Healthcare

The Global Oncology Informatics market is bolstering the growth owing to technological advancement and the need for reducing medical cost. The global oncology informatics market has the potential to grow with USD 8.24 billion with propelling CAGR in the forecast period from 2021-2027. Factors driving the market demand for oncology informatics are increasing cardiovascular diseases, increases medical treatment costs, and moving technology is driving the healthcare industry.

Cancer treatment is a medical field that requires the integration of large amounts of data in the decision-making process. Data integration faces many challenges, including risk assessment, tumor staging, and coordination among specialists in the team.Therefore, in the coming years, computer analysis and modeling tools can be used to integrate data in multiple formats provided by high-throughput technologies (such as genomics, proteomics) to avoid overtreatment and achieve personalized disease management.Moreover, the comparison of multiple data sources in the clinical workflow can improve the accuracy of diagnosis and treatment and optimize cost-effectiveness. Oncology informatics helps in advancing the development of cardiovascular and cancer medicine requires intelligent IT tools and interdisciplinary data processing strategies.

Type overview in the Global Oncology Informatics Market

Based on the type, the global oncology informatics market segmented into Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support System (CDSS), Drug Discovery and Development Informatics. The clinical decision support system segment accounted for the largest share in the global oncology informatics market. It is mainly to the field of cardiovascular medicine, and integrated decision support tools can not only improve diagnosis and treatment results and work efficiency but also save costs. Also, the number of patients with cardiovascular diseases is increasing, and the related knowledge base and the disease data that doctors need to deal with are also growing. Thus, CDSS will help in analyzing patient disease better and improves its treatment and recovery process.

Get more information on this report: Download Free Sample PDF

Application overview in the Global Oncology Informatics Market

Based on the application, the global oncology informatics market segmented into Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Others. Colorectal cancer dominates the most significant share for the market oncology informatics. With the advancement of technology and integrated diagnostic methods helps in treating the inter and intratumor levels caused by colorectal cancer.

End-Users overview in the Global Oncology Informatics Market

Based on the end-user, the global oncology informatics market classified into Pharmaceutical Industry, Life Science Industry, Contract Research Organizations (CROs), Academic Institutes and Research Centers, Others. The research centers segment has dominated the largest share in the global oncology informatics market. The enhancement of medical treatment methods and integration of analytic tools helps in fueling the pharmaceutical sector, and investment in research and development of research centers is bolstering the market of the oncology informatics market.

Region overview in the Global Oncology Informatics Market

Based on geography, the global oncology informatics market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. Asia Pacific region is dominating the market share of the global oncology informatics market. It is mainly due to the rising development in the healthcare industry, the advancement of new technology, and analytics tools for treating cancer patients and improve their treatment process and recovery as well.

Global Oncology Informatics Market: Competitive Landscape

Companies such as Cerner Corporation, Change Healthcare, Elekta AB, F.Hoffmann-La Roche Ltd., Hologic Inc., IBM Corporation, Inspirata Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, McKesson Corporation, MIM Software, Inc. Oncology Analytics, Inc., PerkinElmer, Inc., RELX Group, Sirenas LLC, UnitedHealth Group, Inc., and Varian Medical Systems, Inc, and others are key players in the global oncology informatics market.

1. Research Strategic Development

1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation

2. Research Methodology

2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation

3. Executive Summary

4. Market Insights

4.1. Economic Factor Analysis
4.1.1. Drivers
4.1.2. Trends
4.1.3. Opportunities
4.1.4. Challenges
4.2. Competitors & Product Analysis
4.3. Regulatory Framework
4.4. Company market share analysis, 2019
4.5. Porterâ€™s Five forces analysis
4.6. New Investment Analysis
4.7. PESTEL Analysis

5. Global Oncology Informatics Market Overview

5.1. Market Size & Forecast, 2016-2027
5.1.1. Demand
5.1.1.1. By Value (USD Million)
5.2. Market Share & Forecast, 2016-2027
5.2.1. By Type
5.2.1.1. Electronic Health Records (EHRs)
5.2.1.2. Population Health Management (PHM)
5.2.1.3. Clinical Decision Support System (CDSS)
5.2.1.4. Drug Discovery and Development Informatics
5.2.2. By Application
5.2.2.1. Breast Cancer
5.2.2.2. Prostate Cancer
5.2.2.3. Colorectal Cancer
5.2.2.4. Cervical Cancer
5.2.2.5. Others
5.2.3. By End-User
5.2.3.1. Pharmaceutical Industry
5.2.3.2. Life Science Industry
5.2.3.3. Contract Research Organizations (CROs)
5.2.3.4. Academic Institutes and Research Centers
5.2.3.5. Others (Hospitals and Other Care Facilities)
5.2.4. By Region
5.2.4.1. Europe
5.2.4.2. North America
5.2.4.3. Asia Pacific
5.2.4.4. South America
5.2.4.5. Middle East & Africa

6. Europe Oncology Informatics Market Overview

6.1. Europe Oncology Informatics Market Size & Forecast, 2016-2027
6.1.1. Demand
6.1.1.1. By Value (USD Million)
6.2. Europe Oncology Informatics Market Share & Forecast, 2016-2027
6.2.1. By Type
6.2.1.1. Electronic Health Records (EHRs)
6.2.1.2. Population Health Management (PHM)
6.2.1.3. Clinical Decision Support System (CDSS)
6.2.1.4. Drug Discovery and Development Informatics
6.2.2. By Application
6.2.2.1. Breast Cancer
6.2.2.2. Prostate Cancer
6.2.2.3. Colorectal Cancer
6.2.2.4. Cervical Cancer
6.2.2.5. Others
6.2.3. By End-User
6.2.3.1. Pharmaceutical Industry
6.2.3.2. Life Science Industry
6.2.3.3. Contract Research Organizations (CROs)
6.2.3.4. Academic Institutes and Research Centers
6.2.3.5. Others (Hospitals and Other Care Facilities)
6.2.4. By Country
6.2.4.1. Germany
6.2.4.2. UK
6.2.4.3. France
6.2.4.4. Italy
6.2.4.5. Rest of Europe
6.2.5. Company Market Share (Top 3-5)
6.2.6. Economic Impact Study on Europe Oncology Informatics Market

7. North Oncology Informatics Market Overview

7.1. North America Oncology Informatics Market Size & Forecast, 2016-2027
7.1.1. Demand
7.1.1.1. By Value (USD Million)
7.2. North America Oncology Informatics Market Share & Forecast, 2016-2027
7.2.1. By Type
7.2.1.1. Electronic Health Records (EHRs)
7.2.1.2. Population Health Management (PHM)
7.2.1.3. Clinical Decision Support System (CDSS)
7.2.1.4. Drug Discovery and Development Informatics
7.2.2. By Application
7.2.2.1. Breast Cancer
7.2.2.2. Prostate Cancer
7.2.2.3. Colorectal Cancer
7.2.2.4. Cervical Cancer
7.2.2.5. Others
7.2.3. By End-User
7.2.3.1. Pharmaceutical Industry
7.2.3.2. Life Science Industry
7.2.3.3. Contract Research Organizations (CROs)
7.2.3.4. Academic Institutes and Research Centers
7.2.3.5. Others (Hospitals and Other Care Facilities)
7.2.4. By Country
7.2.4.1. US
7.2.4.2. Canada
7.2.4.3. Mexico
7.2.5. Company Market Share (Top 3-5)
7.2.6. Economic Impact Study on North America Oncology Informatics Market

8. Asia Pacific Oncology Informatics Market Overview

8.1. Asia Pacific Oncology Informatics Market Size & Forecast, 2016-2027
8.1.1. Demand
8.1.1.1. By Value (USD Million)
8.2. Asia Pacific Oncology Informatics Market Share & Forecast, 2016-2027
8.2.1. By Type
8.2.1.1. Electronic Health Records (EHRs)
8.2.1.2. Population Health Management (PHM)
8.2.1.3. Clinical Decision Support System (CDSS)
8.2.1.4. Drug Discovery and Development Informatics
8.2.2. By Application
8.2.2.1. Breast Cancer
8.2.2.2. Prostate Cancer
8.2.2.3. Colorectal Cancer
8.2.2.4. Cervical Cancer
8.2.2.5. Others
8.2.3. By End-User
8.2.3.1. Pharmaceutical Industry
8.2.3.2. Life Science Industry
8.2.3.3. Contract Research Organizations (CROs)
8.2.3.4. Academic Institutes and Research Centers
8.2.3.5. Others (Hospitals and Other Care Facilities)
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. Australia
8.2.4.5. Rest of Asia Pacific
8.2.5. Company Market Share (Top 3-5)
8.2.6. Economic Impact Study on Asia Pacific Oncology Informatics Market

9. South America Oncology Informatics Market Overview

9.1. South America Oncology Informatics Market Size & Forecast, 2016-2027

9.1.1. Demand
9.1.1.1. By Value (USD Million)
9.2. South America Oncology Informatics Market Share & Forecast, 2016-2027
9.2.1. By Type
9.2.1.1. Electronic Health Records (EHRs)
9.2.1.2. Population Health Management (PHM)
9.2.1.3. Clinical Decision Support System (CDSS)
9.2.1.4. Drug Discovery and Development Informatics
9.2.2. By Application
9.2.2.1. Breast Cancer
9.2.2.2. Prostate Cancer
9.2.2.3. Colorectal Cancer
9.2.2.4. Cervical Cancer
9.2.2.5. Others
9.2.3. By End-User
9.2.3.1. Pharmaceutical Industry
9.2.3.2. Life Science Industry
9.2.3.3. Contract Research Organizations (CROs)
9.2.3.4. Academic Institutes and Research Centers
9.2.3.5. Others (Hospitals and Other Care Facilities)
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Argentina
9.2.4.3. Rest of South America
9.2.5. Company Market Share (Top 3-5)
9.2.6. Economic Impact Study on South America Oncology Informatics Market

10. Middle East & Africa Oncology Informatics Market Overview

10.1. Middle East & Africa Oncology Informatics Market Size & Forecast, 2016-2027
10.1.1. Demand
10.1.1.1. By Value (USD Million)
10.2. Middle East & Africa Oncology Informatics Market Share & Forecast, 2016-2027
10.2.1. By Type
10.2.1.1. Electronic Health Records (EHRs)
10.2.1.2. Population Health Management (PHM)
10.2.1.3. Clinical Decision Support System (CDSS)
10.2.1.4. Drug Discovery and Development Informatics
10.2.2. By Application
10.2.2.1. Breast Cancer
10.2.2.2. Prostate Cancer
10.2.2.3. Colorectal Cancer
10.2.2.4. Cervical Cancer
10.2.2.5. Others
10.2.3. By End-User
10.2.3.1. Pharmaceutical Industry
10.2.3.2. Life Science Industry
10.2.3.3. Contract Research Organizations (CROs)
10.2.3.4. Academic Institutes and Research Centers
10.2.3.5. Others (Hospitals and Other Care Facilities)
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of Middle East & Africa
10.2.5. Company Market Share (Top 3-5)
10.2.6. Economic Impact Study on Middle East & Africa Oncology Informatics Market

11. Competitor Analysis

11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1.1. Cerner Corporation
11.7.1.2. Change Healthcare
11.7.1.3. Elekta AB
11.7.1.4. F.Hoffmann-La Roche Ltd.
11.7.1.5. Hologic Inc.
11.7.1.6. IBM Corporation
11.7.1.7. Inspirata Inc.
11.7.1.8. Koninklijke Philips N.V.
11.7.1.9. Laboratory Corporation of America Holdings
11.7.1.10. McKesson Corporation
11.7.1.11. MIM Software, Inc.
11.7.1.12. Oncology Analytics, Inc.
11.7.1.13. PerkinElmer, Inc.
11.7.1.14. RELX Group
11.7.1.15. Sirenas LLC
11.7.1.16. UnitedHealth Group, Inc.
11.7.1.17. Varian Medical Systems, Inc
11.7.1.18. Other players

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1